Accidental contamination from pathogenic lab sampling and testing is always a possibility, and is a critical reason for both in-house and third-party labs to create and follow biosafety plans specific to their operations. A lab’s biosafety plan should include handling of samples, lab access, and employee training and safety procedures, based on the CDC guidance document, Biosafety in Microbiological and Biomedical Laboratories (BMBL).
Click here to read the entire story.
Latest from Quality Assurance & Food Safety
- FDA, CDC Investigate Salmonella Outbreak Linked to Live It Up Dietary Supplement Powder
- USDA FSIS Announces New Deputy Administrator of Field Operations
- ProVeg Incubator Launches Fast-Track to Impact Program for Alt-Protein Startups
- Kerry Releases 2026 Global Taste Charts
- FDA Shares Australia Certificate Requirements for Bivalve Molluscs and Related Products
- FDA Announces Update from CFIA on Certificate Requirements for Certain Meat, Poultry Products
- NIMA Partners Introduces the Next-Generation NIMA Gluten Sensor
- IFT to Host Community Conversation on Dietary Guidelines for Americans, 2025-2030 Report
